Our CEO, Dr. Rozenblum, will be participating at #BiopharmAmerica this year. He can't wait to showcase how Aplife is revolutionizing the high-throughput chemical synthesis industry. Stay tuned for updates on our innovative technologies and advancements
Happy #DNADay! Let's celebrate the impact DNA has had on advancing new therapies & diagnostics. DNA tech has revolutionized healthcare & has the potential to improve the quality of life for many. #DNA#therapies#diagnostics#healthcare#biotechnology
Our CSO, Dr. @grozenblum, will present our breakthrough technology at #Medinvest. If you're in the vicinity and would like to learn more about the future of digital biosensors, don't hesitate to get in touch with us! #innovation#technology#biosensors#medtech
We’re excited to announce that @AplifeBiotech’s CSO, will be attending the upcoming Bio CEO & Investor Conference in New York. Guido will be networking with potential partners and investors, discussing our innovative biosensing technology and how we can create a better future.
Yesterday, Aplife Biotech had the great honor of presenting our cutting-edge technology to leaders in the semiconductor industry. We are incredibly thankful to Silicon Catalyst for inviting us to participate in their event!
It was a great pleasure to be selected to showcase Aplife’s technology at the G20 Digital Innovation Network convention.
We thank the organizer for the great event that was held in Bali, Indonesia.
We are excited to show our breakthrough technology at Resi. This is a great opportunity to meet investors and collaborators that shares our innovative culture and wants to contribute to create the future of portable digital health and environmental diagnostics. Meet us in Boston
We are thrilled to announce that Aplife Biotech has been selected as a top 5 startup representing Argentina at the @g20org Digital Innovation Network in Digital Healthcare.
We are excited to have this opportunity to showcase our work and continue growing our business.
Did you know that Aplife is building a technology that will help biosensor manufacturers to bring to market products faster with novel detection elements?
Our high-throughput screening technology will enable companies to discover detection probes more quickly than ever before!
Aplife is growing, and it´s time to leave the nest. We need a larger place to continue working on a technology that will change medical and environmental diagnostic assays. See you soon in our new headquarters!
Today is the International DNA DAY, and we celebrate it because DNA will bring the solutions of the future that will make us all live an improved life. At Aplife, we use DNA to develop digital biosensors that will move medical and environmental diagnostics where is needed.
We want to give a special thank you to Robert Umek for his Assistance at Aplife Biotech. We are creating an unrivaled technology. To do something that nobody did it before, we need the help of outstanding people! Thanks Robert!
At Aplife we think big, and we are creating the future of portable diagnostics with a platform capable of digitally studying 20 million molecular probes. We are making the real Digital Health, and you are invited to be part of the next diagnostic revolution.
At Aplife, we work on a technology that converts molecular interactions into electricity, filling the gap between detecting a biomarker of interest and obtaining a digitalized result.
We need to create tools that don´t exist.
We build electrical circuits to read the biological world. What would you detect if you could simultaneously study 24 different health-related or environmental biomarkers with a small portable device in almost real-time? We can do it. But why stop there?
We want to welcome Dr. Peter Levine from the University of Waterloo. He has contributed to original developments in the field of bioelectronics fabricating CMOS sensors to study the biological world. We are thrilled to have Dr. Levine as an advisor.
At Aplife, we need to test a combination of materials and unique fabrication processes to accomplish our goals, and we are excited to have Dr. Kim as an advisor. #nanotechnology#semiconductors
More good news from Aplife. Sung Jin Kim has joined Aplife´s advisory board. Dr. Kim is an expert in nanofabrication, nanomaterials, and biochemical sensors. He is an active contributor to novel scientific advancements in photonics, materials, and sensors.